This website sets cookies which are used to offer a personalized experience on our website, generate statistics, and realize advertising or social network tracking. Find out more about our Privacy & Cookie policy and how to manage them on your browser. You can change your cookie settings at any time.

Press Ctrl + G to search for a speaker



Professor The Kirby Institute, UNSW Sydney Jason Grebely is a Professor and Head of the Hepatitis C and Drug Use Research Group at the Kirby Institute at UNSW Sydney.

Zoë R


PhD Candidate Dalla Lana School of Public Health, University of Toronto Zoë Greenwald is a PhD Candidate in Epidemiology at University of Toronto and holds a Master's of Epidemiology from McGill University. She is a proud CanHepC Doctoral Trainee with a passion for hepatitis C and harm reduction research.



Associate Professor McMaster University Dr. Greenwald the current program director for the Gastroenterology Residency Program at McMaster University and he is a Skills Enhancement in Endoscopy (SEE) program instructor for CAG.



Assistant Professor McGill University Dr. Gregorieff is an Assistant Professor in the Department of Pathology at McGill University and has established his lab at the Research Institute of the McGill University Heath Centre since 2017. Dr. Gregorieff has a long standing interest in understanding the mechanisms underlying gastro-intestinal stem cell homeostasis and regeneration with a particular focus on dissecting the role of Wnt and Hippo Signaling in this context.



Associate Professor University of Toronto Dr. Samir C. Grover is a Clinician-Educator in the Division of Gastroenterology at St. Michael’s Hospital and an Associate Professor in Gastroenterology in the Department of Medicine of the University of Toronto, where he serves as the residency program director. Dr. Grover’s research is in the application of simulation and technology-enhanced learning strategies to endoscopy education. His research work has evaluated simulation to teach technical and non-technical skills in endoscopy, ergonomic behaviours, and AI as applied to endoscopic education. His work has help define competencies that are used in gastroenterology residency training programs for endoscopy in Canada.

Mackenzie W


MD/PhD Student University of Calgary Mackenzie is an MD/PhD student at the University of Calgary. She is currently competing her PhD project which is focused on the role the early-life mycobiome in obesity development and metabolic inflammation.



Assistant Professor University of Saskatchewan Trained in medicine at McMaster - EBM routes  Completed GI fellowship in Ottawa  Started practice as an internist and gastroenterologist in the arctic (NWT)  Moved to practice tertiary centre Gastroenterology in the Middle East  Completed Intestinal Ultrasonography training in Milan, Italy and Lueneburg, Germany  Doctoral Candidate, Doctorate of Education, University of Calgary  Uses intestinal ultrasonography (IUS) in clinical practice every day.



PhD student Université de Sherbrooke Maude is a PhD student at the University of Sherbrooke and she is working on the esophagus in Véronique Giroux's lab.



PhD Student McMaster University Amber is a PhD student in the Verdu lab at McMaster University.



Centre hospitalier de l'Université de Montréal Dr Hercun joined the Liver Unit at the CHUM in Montreal in 2021. He completed a fellowship at the Liver  Diseases Branch of the National Institute of Diabetes, Digestive and Kidney Diseases of the NIH. His  clinical and research interest include auto-immune liver disease and hepatic involvement in systemic diseases.



Associate Professor University of Calgary Dr. Hirota is an Associate Professor and Canada Research Chair in Host-Microbe Interactions in Chronic Disease at the University of Calgary in the Snyder Institute for Chronic Diseases. His team’s research interests are broad, spanning from understanding the role microbial metabolites in the regulation of intestinal mucosal homeostasis, elucidating the mechanism(s) driving intestinal fibrosis and pathogenic tissue remodelling in Crohn’s disease, to characterizing the interplay between various mucosal immune cells and IL-22 in the context of health and disease.



Hepatologist Toronto Centre for Liver Disease Dr Hirschfield is a Staff Hepatologist and Professor at Toronto Centre for Liver Disease. His practice is focussed on autoimmune liver disease pre- and post-transplant



Research Associate Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM) Stine is a social epidemiologist whose research centres on the study of drug use, drug-related harms, and access to health and prevention services for people who inject drugs, with a particular focus on behavioural, social and structural determinants of health. She is a lead investigator on the Virtual Cascade of Care Cohort study, combining community-based recruitment with administrative data linkage to study access to HCV care among people with a history of injection drug use.



Gastroenterologist Queen's University Therapeutic gastroenterologist, research interests include quality assurance, colonoscopy preparation, and prevention of post ERCP pancreatitis.



Gastroenterologist/Assistant Professor Mount Sinai Hospital/University of Toronto Dr. Huang completed medical school and internal medicine residency at Queen’s University, Gastroenterology fellowship at the University of Toronto. She completed an Advanced IBD clinical research fellowship and Masters of Science (Medicine) at the University of Alberta where she developed the Northern Alberta Preconception and Pregnancy in IBD clinical research program. In late 2017 she moved back to Toronto, she established the Mount Sinai Hospital Preconception and Pregnancy in IBD clinical research program in 2017/2018. She currently is an Assistant Professor and Clinician Investigator at Mount Sinai Hospital and University of Toronto. Her primary clinical research interests include using multidisciplinary approaches and e-health strategies to incorporate P4 (predictive, preventive, participatory, personalized) medicine to optimize maternal, fetal, and neonatal outcomes in IBD, and conducting translational studies investigating the impact of maternal IBD and therapies on the fetus and neonate.



PGY5 Pediatric Gastroenterology Subspecialty Resident University of Alberta A current final year pediatric gastroenterology subspecialty resident at the University of Alberta in Edmonton.



Head, Liver Failure Group UCL Medical School My work focuses on liver failure. The most important observation we made was the discovery that systemic inflammation played a crucial role in the progression of liver injury and cirrhosis culminating in liver failure leading up to current hypotheses and the seminal observation that acute-on-chronic liver failure (ACLF) was a distinct clinical syndrome with defined clinical, prognostic and pathophysiological characteristics. ACLF is associated with high mortality rates, consumes huge healthcare resources and its treatment is a huge unmet need. In the past 15 years since I described this syndrome first, more than 800 papers have been published on this subject and many research groups and industry are focussed on this subject to better define, prognosticate, understand its pathogenesis and develop new treatments.



MD and Associate Professor Dalhousie University, QE II Health Sciences Center, Halifax, NS Dr. Jones completed her gastroenterology residency at Dalhousie University and IBD, subspecialty training at Mayo Clinic, Rochester MN, After this she completed her MSc in Epidemiology at the University of Calgary. More recently she obtained her Implementation Science Certification through UCSF. An Associate Professor of medicine at Dalhousie University, QE II Health Sciences Center, she serves as Medical co-lead of the NSCIBD Program and Chair of the Department of Medicine Clinical Systems and Innovation Committee. Her research interests include patient-oriented research, health systems, and implementing and evaluating models of care for IBD.



Associate Professor University of Windsor Phillip Karpowicz is an Associate Professor in the Department of Biomedical Sciences at the University of Windsor. He completed his Ph.D. at the University of Toronto and was a Postdoctoral Fellow at Harvard Medical School. His research focuses on intestinal stem cells, how these are regulated by circadian rhythms in the intestine and colon, and how diseases such as IBD may be affected by the loss of circadian rhythms.



Professor of Critical Care and Hepatology University of Alberta Dr. Constantine (Dean) Karvellas is a Professor of Medicine (Critical Care Medicine and Gastroenterology/Hepatology) at the University of Alberta and an Adjunct Professor in the School of Public Health Sciences. He has been an attending intensivist in the E. Garner King General Systems Intensive Care Unit since 2009 and is involved with the Liver Transplant program as a Hepatologist. Dr. Karvellas is the only Canadian co-investigator in the NIH-funded United States Acute Liver Failure study group (US ALFSG). He is an Associate Editor for the Journal of Hepatology and the American Journal of Transplant. Dr. Karvellas' publications reflect his interests in acute liver failure (ALF), acute on chronic liver failure (ACLF), liver transplantation and extracorporeal liver support.



Assistant Professor Queen's University I completed medical school and internal medicine training at Memorial University before moving on to Ontario to complete GI fellowship at Queen's University and a Clinical Hepatology Fellowship at the Toronto Western Hospital. Practiced in St. John's, Newfoundland for four years before returning to Ontario where I am currently an Assistant Professor with the GI Division at Queen's University.



Assistant professor, department of surgery Dalhousie University Completed medical school and residence at Dalhousie University. Trained in colorectal surgery at the university of Calgary. On faculty at Dalhousie university since 2014 with primary interests in resident education and surgical management of IBD



Clinical Assistant Professor University of Calgary Dr Kim is a general practitioner in Calgary with special interest in diabetes and migraine, and is a clinical assistant professor at University of Calgary. He works as a peer reviewer for numerous international journals. In Diabetes Canada, he has various role including being in a steering committee for the Clinical Practice Guideline. He has given various presentations nationally on topics of diabetes, migraine, ADHD, binge eating disorder and medical education. He is currently a Masters student at University of Toronto in Health Practitioner Teacher Education.

Heather Mary-Kathleen


Clinical Fellow University Health Network Dr. Heather Kosick is a 2022-2023 recipient of a CASL fellowship in clinical hepatology. She is currently completing her fellowship at the University of Toronto, which is where she also completed training in internal medicine and gastroenterology. Her primary research interest involve NAFLD fibrosis and the use of machine learning techniques for prediction of liver-related outcomes.



Post-doctoral fellow McMaster University I am coming from France with a background in animal behavior and microbiology. I am currently working in a postdoctoral project, in Drs. Bercik & Collins laboratory, investigating the role of gut microbiota in mental health and disease using germ-free and gnotobiotic mouse models.



Assistant Professor of Medicine McGill University Health Centre Dr. Kronfli is an Assistant Professor of Medicine in the Division of Infectious Diseases at the McGill University Health Centre and a Clinician-Scientist at the Research Institute of the McGill University Health Centre. She is also Vice-Chair of the International Network of Health and Hepatitis in Substance Users (INHSU) Prisons Network. Her research focuses on designing, deploying, and evaluating evidence-based models of care that aim to increase engagement along the hepatitis C virus care cascades for vulnerable populations, with a particular focus on incarcerated populations.



Canadian Medical Protective Association Canadian Medical Protective Association Dr. Katherine Larivière is a medical educator and Family Physician from Ottawa. She practiced in a number of settings including clinical teaching and administrative roles with the University of Ottawa Family Medicine residency program and work in quality improvement and physician wellness before joining the CMPA in 2017. She now delivers educational programming and provides medico-legal advice to CMPA member physicians across Canada.



Associate Professor University of Alberta Dr. Adriana Lazarescu is an Associate Professor at the University of Alberta. She completed her Gastroenterology residency at Queen’s University followed by a CIHR-funded clinical research fellowship in Esophageal Motility at the Catholic University of Leuven in Belgium. She is director of the GI Motility Lab at the University of Alberta Hospital in Edmonton and director of the Neurogastroenterology and Motility fellowship program at the University of Alberta. Her main clinical and research interests are in GI motility and medical education.



Professor Dalhousie University Desmond Leddin MB, MSc, FRCPC, FRCPI graduated from Trinity College Dublin. He completed postgraduate training in Internal Medicine and Gastroenterology at Queens University, Ontario and at the University of Toronto before completing a Masters in Physiology at Queens on intestinal inflammation. He has chaired the Royal College of Canada examination board in Gastroenterology, the Canadian Association of Gastroenterology education committee, and has been director of training canters and education for the World Gastroenterology Organisation. He was head of the Dalhousie University Division of Gastroenterology and district clinical head for Medicine. He is a past President of the Canadian Association of Gastroenterology. Research interests are inflammatory bowel disease, colon cancer screening, Gastroenterology practice in lower income countries, medical education, and climate change. He wrote the first review on the implications of climate change for digestive health and most recently has published a study of global GI leadership and the climate crisis. As chair of the WGO research committee he initiated the climate action group. He is currently adjunct Professor of Medicine at Dalhousie University, Canada and adjunct professor at University of Limerick in Ireland.



Professor of Medicine University of Calgary Professor of Medicine and hepatologist, University of Calgary Cumming School of Medcine. I first met Victor Feinman 4 decades ago when I was a GI fellow in Toronto.



Toronto Community Hep C Program Treatment RN South Riverdale Community Health Centre Bernadette Lettner is a treatment RN with the Toronto Community Hepatitis C Program (TCHCP), and works throughout downtown and east Toronto. She brings a strong health equity focus to her work providing care and treatment access to individuals living with Hepatitis C.

Jiafeng (Jeff)


PhD candidate University of Ottawa Jeff is a PhD candidate and CanHepC trainee in Dr. Angela Crawley’s lab at the Ottawa Hospital Research Institute and the University of Ottawa. Before moving to Ottawa, Jeff obtained his BSc in Microbiology and Immunology at McGill University, in his hometown of Montreal. His current research focuses on blood-derived CD8+ T cell function in the context of advanced liver disease, with specific interest in pathways related to T cell activation. Besides immunology, Jeff also has personal interests in the application of research in public health and policy-making.



Research Associate The Hospital for Sick Children 2014-Present Researchn Fellow / Associate, The Hospital for Sick Children, Canada 2015 January Ph. D. in Cell and Developmental Biology, University College London, UK



Medical Oncology BC Cancer Howard Lim is a Medical Oncologist at B.C Cancer - Vancouver Centre and Clinical Associate Professor in the Faculty of Medicine at the University of British Columbia. He was the residency program director and is one of the Co-Leads for Competency Based Medical Education Implementation at UBC. He specializes in gastrointestinal malignancies and is also actively involved in clinical trials, ethics and genomic based research.



The Hospital for Sick Children Dr Ling is a paediatric hepatologist at SickKids and the University of Toronto, who has undertaken clinical studies of CF liver disease throughout his career, most recently within the CFLD Research Network, and the CFLD genetic modifier study consortium. He is a co-author of the recently updated CF Foundation Clinical Practice Guideline for hepatobiliary disease in CF.



Coordinator HCV POCT Training and Help4Hep

A person with hep C lived experience, who was inspired to engage in advocacy for people affected by hep C and raise awareness, educate, and support his peers. He considers all people at risk and people who are working to support people who have living or lived experience with hep C to be his peers. Central to his efforts in recent years is efforts to bring all people who see elimination as our shared goal, together, with shared and diverse ambitions and approaches to see this come to fruition. This includes all of the populations identified as priority populations, as indicated in the Blueprint and various road maps as they apply in PT of Canada, specifically in the context of community based efforts, in collaboration with the clinical, research, public health sectors who are engaged in this work.



Prof. Medicine University of Alberta Prof. Medicine University of Alberta



Head, DIvision of Gastroenterology St. Michael's Hospital Dr. Gary May received his MD from the University of Alberta in Edmonton, Alberta, Canada(1985), completed his internship and internal medicine training at the University of British Columbia, and his Gastroenterology training at the University of Calgary (1991). Dr. May completed his fellowship training in biliary and advanced therapeutic endoscopy at Duke University Medical Centre, Durham, North Carolina under the mentorship of Dr. Peter Cotton(1993). From 1993 to 2004, Dr. May was on the faculty at the University of Calgary where he practiced at the Foothills Hospital. In 2004, Dr. May was recruited to St. Michael's Hospital where his interests as a clinician teacher are in advanced therapeutic endoscopy including ERCP, endoscopic ultrasound and endoscopic oncology including advanced EMR , POEMS and ESD . He is a co-director of the successful International Therapeutic Endoscopy Course held annually at St. Michael’s Hsopital. He is currently the head of the Division of Gastroenterology at St. Michael’s Hospital.



Assistant Professor University of Ottawa Dr. Jeffrey McCurdy is an Assistant Professor of Medicine at the in the University of Ottawa, and a clinical investigator at the Ottawa Hospital Research Institute. He received his PhD in Immunology from Dalhousie University and his MD from the University of Ottawa. He completed his Gastroenterology training at Dalhousie University, and an advanced fellowship in IBD at Mayo Clinic, Rochester. His research interests focus on identifying predictors of disease related outcomes in IBD, including perianal Crohn’s disease, infectious exacerbations of IBD and venous thromboembolism.



Division Head of General Internal Medicine QE2 Health Sciences Associated with Dalhousie University Dr. Magnus McLeod is specialist of General Internal Medicine and Hepatology at the QEII Health Sciences Centre in Halifax, Nova Scotia. He received his Royal College Diplomate in Hepatology in 2021. He has been on faculty since 2015, currently appointed as an Assistant Professor. He is a member of the Atlantic Multi-Organ Transplant Program (MOTP) with academic and clinical interests including Non-Alcoholic Fatty Liver Disease(NAFLD), Autoimmune Liver Disease, and Liver Transplant. Currently he is the Division Head of General Internal Medicine at the QE2 Health Sciences and a member of the CASL Research Committee and CASL Guidelines Committee.



PhD Candidate University of Calgary Emily Mercer is a Ph.D. Candidate at the University of Calgary in the lab of Dr. Marie-Claire Arrieta. Her research focuses on evaluating gut microbiome maturation in early life using a multi-kingdom perspective.



Assistant Professor Division of Gastroenterology - University of Alberta Completed medical school, his residency in internal medicine, residency in gastroenterology, and master´s degree in medical sciences, at the Autonomous University of Mexico, in Mexico City. Afterwards, he completed his hepatology fellowship at the University of Alberta, and an hepatocellular carcinoma fellowship at the Icahn School of Medicine at Mount Sinai, New York.



E.P. Taylor Professor of Pain Studies McGill University Jeffrey S. Mogil is the E.P. Taylor Professor of Pain Studies, and the immediate-past Director of the Alan Edwards Centre for Research on Pain at McGill University. With an h-index of 93, Dr. Mogil is the author of over 260 journal articles and book chapters since 1992, and has given over 400 invited lectures in that same period. He served as a Councilor at the International Association for the Study of Pain, a Section Editor at the journal, Pain, and as the chair of the Scientific Program Committee of the 13th World Congress on Pain.



GI St. Michael's Hospital Dr. Jeffrey Mosko graduated with a BSc and then MD from the University of Western Ontario. He completed his internal medicine and general gastroenterology training at the University of Toronto. He completed his fellowship training in advanced endoscopy at Beth Israel Deaconess Medical Center  in Boston and has been on staff at St. Michael’s Hospital since that time. He completed an MSc in Quality Improvement and Patient Safety at the University of Toronto. At St. Michael’s Hospital, he serves as the co-director of the advanced endoscopy fellowship and the education site director. His clinical expertise is in both luminal and pancreaticobiliary advanced endoscopy. His research interests are in quality improvement in endoscopy.



Professor Sickkids Dr. Muise is a Clinician-Scientist in the Cell Biology Program and Co-Director of the Inflammatory Bowel Disease (IBD) Centre at the Hospital for Sick Children, University of Toronto. His clinical and research focus centers solely on understanding the pathogenesis of severe forms of intestinal disease in very young children, including inflammatory bowel disease (IBD). Unfortunately, these patients often do not respond to conventional therapies, suffer significant morbidity and are at risk of premature death. The goal of his lab is to develop a precision medicine approach to better treat these young children by elucidating the underlying genetic/functional causes.



Postdoctoral Fellow University of Toronto Dr. Tapas Mukherjee (Ph.D.) is a POSTDOCTORAL FELLOW with Dr. Dana Philpott and Dr. Stephen Girardin in the Department of Immunology / Laboratory Medicine and Pathobiology, at the University of Toronto. Tapas is trained as a microbiologist and as an immunologist. He completed his Ph.D. from the National Institute of Immunology, New Delhi, India. Tapas’s doctoral work has been instrumental in unravelling cell-intrinsic crosstalk between NF-kB signalling system in the context of health and disease. Tapas’s research interests lie in understanding the aspects of host-pathogen interaction, cell-signalling networks and immuno-metabolism linked with human ailments. Currently, a part of his postdoctoral work focuses on elucidating the influence of Crohn’s disease (CD)-associated risk genes, NOD2 and ATG16L1 in disease pathogenesis. Particularly, Tapas aims to decipher the cellular and molecular basis of CD development and related extra-intestinal manifestations. As a postdoctoral fellow, Tapas has been awarded (1) The American Association of Immunologists (AAI) Intersect Fellowship for Computational Scientists and Immunologists (2021-2022), (2) Canadian Institute of Health Research (CIHR) Postdoctoral Fellowship (2022-2024), and (3) “D. H. Gales Family Charitable Foundation Postdoctoral Fellowship” by the Banting & Best Diabetes Centre (BBDC-2022).



Pediatric Gastroenterologist, Clinician-Scientist, and Assistant Professor Queen's University Dr. Mulder is a pediatric gastroenterologist and clinician-scientist at Queen's University in Kingston, Ontario who studies the effects of the immune system on the gastrointestinal tract. He completed his graduate studies and medical school at Queen's University, his pediatric residency at McMaster, and his gastroenterology fellowship at SickKids in Toronto. His CIHR-funded PhD studies focused on the role of antigen presentation in eosinophilic esophagitis.



Postdoctoral Fellow Western University Nick Murphy is a postdoctoral fellow with the Departments of Medicine and Philosophy at Western University in London, Ontario. Dr. Murphy's research concerns ethical issues in organ donation and transplantation, particularly as they relate to innovations in deceased donation practices. His recent work explores the ethical and regulatory challenges facing both abdominal and thoraco-abdominal NRP in the Canadian context.



PhD Candidate Toronto General Hospital Research Institute Diana Nakib is a PhD candidate in the lab of Dr. Sonya MacParland at the Toronto General Hospital Research Institute and Department of Immunology at the University of Toronto. Through multi-disciplinary collaborations and employing multi-omic technologies, Diana is interested in spatially and temporally mapping the cellular landscape of the PSC liver to uncover potential immunotherapeutic drug candidates.



University of Calgary University of Calgary Dr. Yasmin Nasser is an Assistant Professor in the Department of Medicine and a clinician-scientist in the Division of Gastroenterology and Hepatology. She is a member of the Gastrointestinal Research Group and of the Snyder Institute for Chronic Disease. She has been the recipient of several prestigious awards, including a Crohn’s Colitis Canada Rising Star Award, a CAG/CIHR/CCC Fellowship, the John Alexander Stewart Fellowship, and a Young Investigator Award from the American Neurogastroenterology & Motility Society. Dr. Nasser has recognized expertise in visceral pain, functional GI disorders and GI motility. She runs an IBD Chronic Pain Clinic at the University of Calgary, which is unique in Canada, where she treats IBD patients in endoscopic remission who continue to suffer from chronic pain. Dr. Nasser’s CIHR and Weston funded translational research program is focused on the role of the microbiome in the development of chronic pain in IBD.



Chief, Viral Hepatitis and Bloodborne Pathogens National Microbiology Laboratory, Public Health Agency of Canada Dr. Osiowy is Chief of the Viral Hepatitis and Bloodborne Pathogens Section at the National Microbiology Laboratory (NML) in Winnipeg, Manitoba. She received her doctorate in virology at the University of Calgary with post-doctoral training at Health Canada’s Bureau of Microbiology in Ottawa. At the NML she is responsible for managing serological and molecular diagnostic reference services for the five hepatitis viruses, investigating HAV and HBV outbreaks or suspected transmission events, and conducting viral hepatitis research including collaborators such as the Canadian Blood Services and the Canadian Hepatitis B Network. She has developed numerous techniques for HBV and HDV biomarker detection for use in clinical studies. Her research interests focus on the molecular characterization, epidemiology and evolution of HBV and HDV in Canada, Kenya and in the Indigenous peoples of the circumpolar Arctic.